Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis

Registry ID

EUCTR2007-000093-23

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Almirall Hermal GmbH

Start date

2007-05-18

Completion date

2008-12-02

Last update

2026-08-16

Conditions

• actinic keratosis

Summary

The primary variable “improvement of clinical score” will be clinically measured and evaluated to investigate clinical efficacy of Tretinoin, marked as Cordes® VAS, in actinic keratosis. Additionally standardised photo documentation at baseline, interim visit and final visit will be performed.

Locations

• , , Germany

View on source registry